PHARMACIA & UPJOHN INC. OPERATIONS WILL BE HEADED BY UPJOHN's ZABRISKIE WITH PHARMACIA's EKBERG AS CHAIRMAN; COMBINED COMPANY EXPECTS $500 MIL. IN CUTS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".